International Journal of Gynecology & Obstetrics · 1999 · 44 citations · 12 references
PharmacyEndocrinologyPharmacotherapyEndocrine PharmacotherapyWomen's HealthHormonal InfluencesHormonal ManagementMenopause CareMenopause ManagementMenopause PharmacotherapySide EffectsPostmenopausal Hormone TherapyPostmenopausal Osteoporosis TreatmentTibolone TherapyTitration Safety
OBJECTIVE: The purpose of this study was to assess the tolerability and side effects of tibolone (Livial, Organon), a synthetic steroid analogue for the treatment of postmenopausal symptoms, in a large population of patients. METHOD: 1189 postmenopausal patients were included in this study. The patients' blood pressure, body weight, general complaints, and the severity of their climacteric complaints were documented at baseline and after 4 months of tibolone treatment. RESULTS: Tibolone significantly relieved all of the classical menopausal complaints. The proportion of patients with bleeding problems dropped significantly from 15.9% to 6.8%. Other complaints, such as headache, vertigo, nervousness, breast tenderness, and hirsutism were also significantly less frequent than before treatment. Only few women reported other rare side effects, and only 14.4% of women discontinued treatment prematurely. CONCLUSION: Tibolone provides an efficient and safe means of treating the postmenopausal syndrome in every-day practice.
12
Biologic Effects of Transdermal Estradiol
David R. Meldrum, Kenneth A. Steingold, John Lu et al. · New England Journal of Medicine · 1986 · 467 citations
Medicine, Endocrinology, Gynecology +17
[Evaluation of climacteric symptoms (Menopause Rating Scale)].
G.A. Hauser, Ilka Huber, Paul J. Keller et al. · PubMed · 1994 · 130 citations
Nursing, Gynecology, Urology +17